Summary
The product anavar (50mg x 100 tablets/bottle), with an ironlion-lab manufacturer, underwent independent testing to verify its authenticity and potency. The sample, with an unknown batch number, was submitted by ironlion-lab and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxandrolone, with a concentration of 49.13 mg, which is 1.74% below the labeled claim of 50 mg per tablet.
The testing process began on 27 September 2024, with the sample received on 3 October 2024, and analysis completed on 8 October 2024. While the results confirm the presence of Oxandrolone with relatively accurate dosing, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: ironlion-lab
- Product Name: anavar (50mg x 100 tablets/bottle)
- Active Ingredient: Oxandrolone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral (tablet)
Sample Acquisition and Testing
- Task Number: #50026
- Testing Ordered: 27 September 2024
- Sample Received: 3 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ironlion-lab (Manufacturer)
- Analysis Paid For By: ironlion-lab (Manufacturer)
Testing Results
- Specification: 50 mg (as stated on the label)
- Measured Concentration: 49.13 mg
- Accuracy: 98.26% (1.74% below the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/50026_DJD5QUIDNCKV
Evaluation of Manufacturer-Submitted Testing
This analysis highlights that anavar (50mg x 100 tablets/bottle) has a high degree of accuracy in its Oxandrolone concentration. However, as the test was submitted and funded by ironlion-lab, careful evaluation is necessary to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that anavar (50mg x 100 tablets/bottle) contains 49.13 mg of Oxandrolone per tablet, which is 1.74% below the labeled claim. While this batch exhibits strong quality control in terms of accuracy, further testing is recommended to ensure consistency across different product batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical and peptide products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
